The Valley Desk

NCT01101841 · Interventional trial

24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms

Overall registry status Completed

Phase 3

Conditions Hot Flashes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov